Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.

NCT06584513 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 470

Last updated 2025-09-30

No results posted yet for this study

Summary

Among older adults (≥65 years), use of sleeping pills, such as benzodiazepines and other sedative-hypnotics, to treat sleep problems is common. While sleeping pills are effective in the first few weeks of use, their effect diminishes significantly after that. Especially older adults are susceptible to significant adverse effects of sleep pills, yet stopping sleeping pills remains challenging. BE-SAFE aims to conduct a randomised study testing a patient-centred intervention to reduce sleeping pill use and to improve patient safety and quality of care focusing on implementation aspects. The intervention addresses knowledge and practice gaps related to discontinuation of sleeping pills in older adults with sleep problems.

Conditions

  • Benzodiazepines Deprescribing
  • Sleep Problems

Interventions

OTHER

Specific tapering plan for sleep medication, educational and cognitive behavioural therapy elements

The intervention consists of a patient-centred intervention to help patients in deprescribing BSHs and better managing their sleep problems. The material used consists of training modules, brochures, and self-monitoring tools. There are materials for physicians and for patients.

Sponsors & Collaborators

  • Universitat Autonoma de Barcelona

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • National and Kapodistrian University of Athens

    collaborator OTHER
  • Institute of Psychiatry and Neurology, Warsaw

    collaborator OTHER
  • CHU UCL Namur

    collaborator UNKNOWN
  • Université Catholique de Louvain

    collaborator OTHER
  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Nicolas Rodondi, MD, MAS · University Hospital Bern (Inselspital)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2026-02-01
Completion
2026-02-01

Countries

  • Belgium
  • Greece
  • Norway
  • Poland
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06584513 on ClinicalTrials.gov